Developing and Introducing a Dual Prevention Pill

A coalition of partners is developing a novel Dual Prevention Pill (DPP) for prevention of pregnancy and HIV acquisition in high-need countries.

In East and Southern Africa — where the DPP is initially planned for introduction — 65 percent of new HIV infections are amongst women aged 15 and over, and 16 percent of women of reproductive age have an unmet need for contraception. As the “youth bulge” results in millions of young people entering their reproductive years, it will impact efforts to end the HIV epidemic and reduce unintended pregnancies. It is critical to ensure all women have access to both contraception and HIV prevention.